Labcorp announces 2022 fourth quarter and full-year results

Burlington, n.c.--(business wire)--labcorp (nyse: lh), a leading global life sciences company, today announced results for the fourth quarter and year ended dec. 31, 2022, full-year 2023 guidance. “we finished the year strong, with accelerated revenue growth in diagnostics, continued strong underlying fundamentals in drug development and margin expansion,” said adam schechter, chairman and ceo of labcorp.
LH Ratings Summary
LH Quant Ranking